Evidence-minded strength, weight loss, and longevity for men over 50.
I lost 170 pounds, rebuilt in a garage gym, and write about what actually works: lifting, GLP-1s, cardio, sleep, and reading your own bloodwork. No hype, no guru worship.
Latest from the blog
-
Retatrutide vs Zepbound: Is Lilly’s Next Weight-Loss Shot Worth Waiting For?
Retatrutide beat Zepbound’s numbers in its own trials, and it did not need its top dose to do…
-
A Zero Calcium Score Isn’t the Whole Story. But the $2,000 Scan Isn’t Either.
My coronary calcium score is zero. What a zero doesn’t rule out, what a new NEJM study found…
-
Heart Attacks Were 43% Lower With a Statin in Adults Over 70. Cardiovascular Deaths Were Not.
I do not take a statin. I got my ApoB to 59 with about 170 pounds of weight…
GLP-1s & Metabolic Health
-
Retatrutide vs Zepbound: Is Lilly’s Next Weight-Loss Shot Worth Waiting For?
Retatrutide beat Zepbound’s numbers in its own trials, and it did not need its top dose to do…
-
Mounjaro Just Got a Heart Indication. The Trial Behind It Didn’t Beat the Older Drug.
The FDA approved Mounjaro today to lower the risk of heart attack, stroke, and cardiovascular death in adults…
-
Sam Sulek’s NewBioRx Sells “Research Only” Retatrutide. A NewBioRx-Branded Site Showed You How to Inject It, Until This Weekend.
Sam Sulek’s peptide company sold retatrutide in a pre-filled pen “for research use only,” while a site under…
Heart & Bloodwork
-
Heart Attacks Were 43% Lower With a Statin in Adults Over 70. Cardiovascular Deaths Were Not.
I do not take a statin. I got my ApoB to 59 with about 170 pounds of weight…
-
Mounjaro Just Got a Heart Indication. The Trial Behind It Didn’t Beat the Older Drug.
The FDA approved Mounjaro today to lower the risk of heart attack, stroke, and cardiovascular death in adults…
-
ApoB 60: Almost Nobody Needs to Go Lower. Here Is Who Does.
An ApoB of 60 mg/dL sits at about the 10th percentile of untreated American adults, lower than roughly…
Strength & Conditioning
-
Big Toe Arthritis Surgery Won the First Real Trial. My Doctor Still Says Wait.
I’ve got severe big toe arthritis. The first real trial on big toe arthritis surgery beat waiting. My…
-
Cold Plunges Got the Hype. Saunas Got the Evidence.
Cold plunges get the attention, but the sauna is the one with decades of hard-outcome data. What the…
-
GLP-1 Muscle Loss Scared Me Into the Gym. The Fear Was Overblown.
The GLP-1 muscle loss panic scared me into training at 50. It turned out overblown, but the habit…
Preventive Health
-
Retatrutide vs Zepbound: Is Lilly’s Next Weight-Loss Shot Worth Waiting For?
Retatrutide beat Zepbound’s numbers in its own trials, and it did not need its top dose to do…
-
A Zero Calcium Score Isn’t the Whole Story. But the $2,000 Scan Isn’t Either.
My coronary calcium score is zero. What a zero doesn’t rule out, what a new NEJM study found…
-
Heart Attacks Were 43% Lower With a Statin in Adults Over 70. Cardiovascular Deaths Were Not.
I do not take a statin. I got my ApoB to 59 with about 170 pounds of weight…
Hormones & TRT
-
I Take Testosterone. One Low Number Shouldn’t Put You on It.
A single low testosterone reading isn’t a diagnosis. I’m on TRT, and here’s how low testosterone is actually…
-
Legal Doping: How TRT and GLP-1s Let Normal Men Get Fit and Strong After 50
I take two drugs that would get an Olympian banned: testosterone and a GLP-1. I will never compete,…
-
What TRT Actually Did for Me at 53
I was diagnosed with anxiety in 2021, hit 373 lbs in 2024, and started TRT in 2025. The…
Start here
The 170-Pound Rebuild
The food noise went quiet. Then I had to rebuild the rest.
GLP-1 Pipeline Tracker
Every approved and pipeline drug, updated.
Home Gym & Gear
The gym, the gear, and how it got built.
The Newsletter
One evidence-minded email each Sunday.